AU2003241334A1 - In situ generation of viral vectors - Google Patents

In situ generation of viral vectors

Info

Publication number
AU2003241334A1
AU2003241334A1 AU2003241334A AU2003241334A AU2003241334A1 AU 2003241334 A1 AU2003241334 A1 AU 2003241334A1 AU 2003241334 A AU2003241334 A AU 2003241334A AU 2003241334 A AU2003241334 A AU 2003241334A AU 2003241334 A1 AU2003241334 A1 AU 2003241334A1
Authority
AU
Australia
Prior art keywords
viral vectors
situ generation
situ
generation
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241334A
Inventor
Mark Fitchmun
Lei Huang
Steven Josephs
Amena Rahman
Robert E. Sobol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAGNUM THERAPEUTICS
Original Assignee
MAGNUM THERAPEUTICS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAGNUM THERAPEUTICS filed Critical MAGNUM THERAPEUTICS
Publication of AU2003241334A1 publication Critical patent/AU2003241334A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003241334A 2002-04-29 2003-04-29 In situ generation of viral vectors Abandoned AU2003241334A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37635002P 2002-04-29 2002-04-29
US60/376,350 2002-04-29
PCT/US2003/013503 WO2003093486A1 (en) 2002-04-29 2003-04-29 In situ generation of viral vectors

Publications (1)

Publication Number Publication Date
AU2003241334A1 true AU2003241334A1 (en) 2003-11-17

Family

ID=29401333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241334A Abandoned AU2003241334A1 (en) 2002-04-29 2003-04-29 In situ generation of viral vectors

Country Status (2)

Country Link
AU (1) AU2003241334A1 (en)
WO (1) WO2003093486A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems

Also Published As

Publication number Publication date
WO2003093486A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2003238456A1 (en) Viral vector
WO2003062749A8 (en) Schematic generation
AU2003253992A1 (en) Viral vectors containing recombination sites
AU2003286894A1 (en) Hydrogen generator
AU2003219157A1 (en) Power generating system
AU2003265826A1 (en) Electrolyte
AU2003299120A1 (en) Switching mode power supplies
AU2003229998A1 (en) Activation induced deaminase (aid)
AU2002952384A0 (en) Structures
AU2003283705A1 (en) Electro-acoustic resonator
AU2003230395A1 (en) Micro-support structures
AU2003290563A1 (en) Leptin-related peptides
AU2003901876A0 (en) Viral vector
AU2003269638A1 (en) Hydrogen generator
AU2002234951A1 (en) Power generating system
AU2003234023A1 (en) Improvements in loudspeakers
AU2003278525A1 (en) Three-phase mixer-systems
AU2003287188A1 (en) Activation of hcv-specific cells
GB2393321B (en) Plasma generation
AU2003258949A1 (en) Particle generator
AU2002349049A1 (en) Frequency generator
AU2003229987A1 (en) Hydrogen generation
AU2003299168A1 (en) Frequency output generation
AU2003241334A1 (en) In situ generation of viral vectors
AU2003210218A1 (en) Opacifiers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase